<?xml version="1.0" encoding="UTF-8"?>
<ref id="B127">
 <label>127.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>South</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Tomlinson</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Edmonston</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Hiremath</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Sparks</surname>
    <given-names>MA</given-names>
   </name>
  </person-group>. 
  <article-title>Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic</article-title>. 
  <source>Nat Rev Nephrol.</source> (
  <year>2020</year>) 
  <volume>16</volume>:
  <fpage>305</fpage>–
  <lpage>7</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41581-020-0279-4</pub-id>
  <?supplied-pmid 32246101?>
  <pub-id pub-id-type="pmid">32246101</pub-id>
 </mixed-citation>
</ref>
